1,3-Dibutylxanthine → Diethyl [5-(1,3-dibutylxanthin-7-yl)pentyl]phosphonate

HRID 2002

Reaction equation

HRID 2002 reaction equation
[CH2:1]([N:5]1[C:14](=[O:15])[C:13]2[NH:12][CH:11]=[N:10][C:9]=2[N:8]([CH2:16][CH2:17][CH2:18][CH3:19])[C:6]1=[O:7])[CH2:2][CH2:3][CH3:4].Br[CH2:21][CH2:22][CH2:23][CH2:24][CH2:25][P:26]([O:31][CH2:32][CH3:33])(=[O:30])[O:27][CH2:28][CH3:29]>>[CH2:1]([N:5]1[C:14](=[O:15])[C:13]2[N:12]([CH2:21][CH2:22][CH2:23][CH2:24][CH2:25][P:26](=[O:30])([O:31][CH2:32][CH3:33])[O:27][CH2:28][CH3:29])[CH:11]=[N:10][C:9]=2[N:8]([CH2:16][CH2:17][CH2:18][CH3:19])[C:6]1=[O:7])[CH2:2][CH2:3][CH3:4]

Participants

3

Reactant 2

HCID 1014211,3-DibutylxanthineHCID 10924159Diethyl-5-bromopentylphosphonate

Product 1

HCID 17887400Diethyl [5-(1,3-dibutylxanthin-7-yl)pentyl]phosphonate

Procedure

The title substance was prepared from 1,3-dibutylxanthine and diethyl 5-bromopentanephosphonate analogously to Example 9.

Sources & evidence

ORD record
ord-8d917ed641af4aa08c8cf5aa6c47bd70
Source dataset
uspto-grants-1998_03
Patent number
US05728686

Linked notes

Loading…